Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
151,803,139
-
Total 13F shares
-
140,492,459
-
Share change
-
+3,337,424
-
Total reported value
-
$765,707,625
-
Put/Call ratio
-
86%
-
Price per share
-
$5.45
-
Number of holders
-
187
-
Value change
-
+$15,429,772
-
Number of buys
-
70
-
Number of sells
-
108
Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q3 2023
As of 30 Sep 2023,
Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by
187 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
140,492,459 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BlackRock Inc., Matrix Capital Management Company, LP, ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Point72 Asset Management, L.P., Aristotle Atlantic Partners, LLC, and Pictet Asset Management Holding SA.
This page lists
187
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.